Is Boehringer Ingelheim Promeco S.A. de C.V. FDA approved?

Boehringer Ingelheim Promeco S.A. de C.V. holds 1 FDA-registered establishment in Mexico. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Boehringer Ingelheim Promeco S.A. de C.V.'s drugs manufactured?

The FDA register lists Mexico City. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.

What drugs does Boehringer Ingelheim Promeco S.A. de C.V. make?

3 products are listed under Boehringer Ingelheim Promeco S.A. de C.V. in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Boehringer Ingelheim Promeco S.A. de C.V.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 3
Live patents: 0
Countries: 1
Base: Mexico

Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1Relabelling1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Boehringer Ingelheim Promeco S.A. de C.V.	Maiz No. 49, Barrio Xaltocan, Xochimilco, Mexico City, DF 16090, Mexico (MEX)	Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging	1000183111812579472

Catalogue

Drug listings by form and route

3 active NDC listings: 3 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 3.

Dosage form	NDCs
tablet	3

Route	NDCs

Labeller name on the listing	NDCs
boehringer ingelheim promeco s.a. de c.v.	3

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Linsgliptin	tablet	64674-999DRUG FOR FURTHER PROCESSING
-	empagliflozin	tablet	64674-150DRUG FOR FURTHER PROCESSING
-	empagliflozin	tablet	64674-160DRUG FOR FURTHER PROCESSING

Neighbours

Registered in the same town

Fermic, S.A. de C.V.Mexico City, MEX
Selder, S.A. de C.V.Mexico City, MEX

Compare

Comparable companies in Mexico

Schwabe Mexico, S.A. de C.V.1 site · 28 NDC
Sicor de Mexico S.A. de C.V.1 site · 27 NDC
Avon Cosmetics Manufacturing, S. de R.L. de C.V.1 site · 16 NDC
Holiday Labs Mexico, S.A. de C.V.1 site · 15 NDC
Nartex Laboratorios Homeopaticos, S.A. de C.V.1 site · 14 NDC
Degasa, S.A. de C.V.1 site · 11 NDC
Aqua Medica, S.A. de C.V.1 site · 10 NDC
Signa S.A. de C.V.1 site · 9 NDC
Nouryon Chemicals, S.A. de C.V1 site · 8 NDC
Selder, S.A. de C.V.1 site · 8 NDC

Enquiry

Common questions

Is Boehringer Ingelheim Promeco S.A. de C.V. FDA approved?: Boehringer Ingelheim Promeco S.A. de C.V. holds 1 FDA-registered establishment in Mexico. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Boehringer Ingelheim Promeco S.A. de C.V.'s drugs manufactured?: The FDA register lists Mexico City. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.
What drugs does Boehringer Ingelheim Promeco S.A. de C.V. make?: 3 products are listed under Boehringer Ingelheim Promeco S.A. de C.V. in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.